London, UK and Durham, NC – January 23rd, 2024: Phastar, a global specialist biometrics contract research organization (CRO), has announced the launch of Stats Helpdesk, a new initiative designed to provide biotech companies with free access to its team of expert statisticians.
The Stats Helpdesk initiative offers essential support and guidance tailored to address the statistical questions and challenges facing biotech companies. Through a complimentary one-hour, no-obligation consultation, biotech companies can navigate intricate statistical landscapes, optimize study designs, and ensure the accuracy and reliability of their data analyses. The Stats Helpdesk also functions as a platform for fostering knowledge exchange, enabling biotech organizations to capitalize on the expertise offered by the Phastar team to enhance their statistical capabilities and improve their overall statistical proficiency, thereby supporting the progression of their projects and contributing to the broader growth of the biotech sector.
The launch of the new helpdesk comes following Phastar’s successful Biotech Essential Statistics webinar series, which provided expert advice on study design considerations for biotech companies, statistical significance in clinical trials and statistical insights for biotech professionals. The webinars provided Phastar with the opportunity to further its mission of collaboration and allowing access to expert advice within the industry.
Graham Clark, CEO at Phastar said: “With biotech companies developing some of the most exciting new drug products in the pipeline, from gene and cell therapies to biologics, they have a real opportunity to make a difference to thousands of lives around the world. Yet with the complexity of trials and the biometrics discipline growing all the time, smaller and newer companies sometimes lack access to the skills they need to move their promising discoveries through the development pathway as quickly and efficiently as possible.
“The Stats Helpdesk is on hand to help advise on all statistical matters, from study planning & design to data collection, analysis, and dissemination. Managed by top-tier statistical experts with extensive experience across therapeutic areas, the team are dedicated to delivering industry-leading statistical guidance that enables biotech companies to make well-informed, data-driven decisions that accelerate drug development programs. This continues Phastar’s corporate mission to improve human health globally.”
